[
  {
    "ts": "2025-12-23T11:19:48+00:00",
    "headline": "Abbott Wins FDA Clearance for Volt",
    "summary": "New heart device targets atrial fibrillation",
    "url": "https://finance.yahoo.com/news/abbott-wins-fda-clearance-volt-111948093.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "c6bd0bce-c51d-355c-85f9-1b39d7ffe9fd",
      "content": {
        "id": "c6bd0bce-c51d-355c-85f9-1b39d7ffe9fd",
        "contentType": "STORY",
        "title": "Abbott Wins FDA Clearance for Volt",
        "description": "",
        "summary": "New heart device targets atrial fibrillation",
        "pubDate": "2025-12-23T11:19:48Z",
        "displayTime": "2025-12-23T11:19:48Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/4db795aedb685021fe0dc344f8ccfc7a",
          "originalWidth": 416,
          "originalHeight": 416,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/C6yONRHLZhlWoNeIb3coEg--~B/aD00MTY7dz00MTY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/4db795aedb685021fe0dc344f8ccfc7a.cf.webp",
              "width": 416,
              "height": 416,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/axtwgvFMo1V9vEkaNtLlJw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/4db795aedb685021fe0dc344f8ccfc7a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbott-wins-fda-clearance-volt-111948093.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbott-wins-fda-clearance-volt-111948093.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T12:20:00+00:00",
    "headline": "Should You Hold On To BSX Stock Despite Its Premium Valuation?",
    "summary": "Boston Scientific trades at a premium, but strong momentum in WATCHMAN, EP and MedSurg growth keeps long-term shareholders in the game despite valuation risks.",
    "url": "https://finance.yahoo.com/news/hold-bsx-stock-despite-premium-122000453.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "8435fa37-6ced-3408-a5bf-6c2ca8f68c47",
      "content": {
        "id": "8435fa37-6ced-3408-a5bf-6c2ca8f68c47",
        "contentType": "STORY",
        "title": "Should You Hold On To BSX Stock Despite Its Premium Valuation?",
        "description": "",
        "summary": "Boston Scientific trades at a premium, but strong momentum in WATCHMAN, EP and MedSurg growth keeps long-term shareholders in the game despite valuation risks.",
        "pubDate": "2025-12-23T12:20:00Z",
        "displayTime": "2025-12-23T12:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/hold-bsx-stock-despite-premium-122000453.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/hold-bsx-stock-despite-premium-122000453.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            },
            {
              "symbol": "MDT"
            },
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T17:11:30+00:00",
    "headline": "Is Abbott Laboratories Attractively Priced After Recent Share Price Gains And DCF Concerns?",
    "summary": "If you have been wondering whether Abbott Laboratories is still a buy at around $125 a share, you are not alone. This is exactly the kind of stock where valuation really matters. Despite slipping about 2.5% over the last week and 2.3% over the past month, Abbott is still up 10.4% year to date and roughly 11.6% over the last year, which keeps it firmly on investors radar as a steady compounder. Recent attention on Abbott has centered on its medical devices and diagnostics businesses,...",
    "url": "https://finance.yahoo.com/news/abbott-laboratories-attractively-priced-recent-171130725.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "3c2d7175-535b-38cb-afb2-3450fcd6176e",
      "content": {
        "id": "3c2d7175-535b-38cb-afb2-3450fcd6176e",
        "contentType": "STORY",
        "title": "Is Abbott Laboratories Attractively Priced After Recent Share Price Gains And DCF Concerns?",
        "description": "",
        "summary": "If you have been wondering whether Abbott Laboratories is still a buy at around $125 a share, you are not alone. This is exactly the kind of stock where valuation really matters. Despite slipping about 2.5% over the last week and 2.3% over the past month, Abbott is still up 10.4% year to date and roughly 11.6% over the last year, which keeps it firmly on investors radar as a steady compounder. Recent attention on Abbott has centered on its medical devices and diagnostics businesses,...",
        "pubDate": "2025-12-23T17:11:30Z",
        "displayTime": "2025-12-23T17:11:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7zJOBZ6wPnYKbKPRmWh.qQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sc9EgsXKjWnUzlOQpxWhqQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-attractively-priced-recent-171130725.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-attractively-priced-recent-171130725.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-23T16:45:53+00:00",
    "headline": "This Dividend Stock Just Scored an FDA Win. Should You Buy Shares Now?",
    "summary": "Abbott’s latest regulatory progress supports its durable growth narrative. Is now the right time to revisit ABT shares?",
    "url": "https://www.barchart.com/story/news/36764906/this-dividend-stock-just-scored-an-fda-win-should-you-buy-shares-now",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "d135979f-2f2e-3d34-8c21-ead313a82e7d",
      "content": {
        "id": "d135979f-2f2e-3d34-8c21-ead313a82e7d",
        "contentType": "STORY",
        "title": "This Dividend Stock Just Scored an FDA Win. Should You Buy Shares Now?",
        "description": "",
        "summary": "Abbott’s latest regulatory progress supports its durable growth narrative. Is now the right time to revisit ABT shares?",
        "pubDate": "2025-12-23T16:45:53Z",
        "displayTime": "2025-12-23T16:45:53Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/c45c7663791f2fe119b3401a74163bde",
          "originalWidth": 1253,
          "originalHeight": 836,
          "caption": "Abbott Laboratories HQ photo- by Sundry Photography via iStock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dsPZKFs_U4EwmgtOYZU_KQ--~B/aD04MzY7dz0xMjUzO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/barchart_com_477/c45c7663791f2fe119b3401a74163bde.cf.webp",
              "width": 1253,
              "height": 836,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jjK6sxfdbuVP6ipJjpiTvg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/c45c7663791f2fe119b3401a74163bde.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/36764906/this-dividend-stock-just-scored-an-fda-win-should-you-buy-shares-now",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/dividend-stock-just-scored-fda-164553663.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]